Medical News Hubb
Advertisement
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us
No Result
View All Result
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us
No Result
View All Result
Medical News Hubb
No Result
View All Result
Home Pharmaceutical

Pandemic response gets a permanent home at the White House

admin by admin
December 22, 2022
in Pharmaceutical



WASHINGTON — The era of the rotating cast of public health czars at the White House may finally be over.

Presidents for decades have brought fresh faces to the White House to coordinate federal responses to threats such as Covid-19, mpox, Ebola, AIDS, and the bird flu.

Now, Congress aims to give pandemic response a permanent home at the White House.

advertisement

Next year’s government funding package includes a brand-new White House Office of Pandemic Preparedness and Response Policy that would have a director appointed by the president and up to 25 staff members.

“They’re not simply going to retire the role that [White House Covid-19 response coordinator Ashish Jha] plays when the emergency declaration ends,” said J. Stephen Morrison, a senior vice president at the Center for Strategic and International Studies and the director of its Global Health Policy Center. “You can’t just keep piling on coordinators, disease by disease.”

advertisement

The new director’s main responsibilities would be to advise the president on preparing for pandemics and other biological threats, to coordinate response activities across the federal government — including research into new countermeasures and distribution of medical supplies — and to evaluate the government’s readiness. The director would also be a member of the Domestic Policy Council and the National Security Council.

“The functions outlined are exactly what is needed at the White House, and what I’ve been calling for for years, to avoid having any single agency take the lead on something that overlaps most departments in the U.S. government,” said Ken Bernard, who worked in biodefense policy in both the Clinton and George W. Bush White Houses.

Some of the responsibilities of the new office seem like they overlap quite a bit with the existing NSC Directorate for Global Health Security and Biodefense, which is currently run by Raj Panjabi, Bernard said. Morrison also said there could be a consolidation effort to ensure global and domestic responses are coordinated under the new office.

Neither the White House nor the National Security Council responded to an inquiry about the role of the new office.

It’s also unclear from the legislative text whether the office would have its own budget.

One of the most important factors for the new office’s success would be whether officials leading the defense and health departments truly believe that the new director actually has the backing and authority of the president to direct spending plans and coordinate resources, Bernard said.

“The president will have to be clear that this director speaks for me,” Bernard said.

Demands on the new office would start right away. Within the first year of the office’s operation, the director would have to compile a preparedness outlook report that would be made public. The director would also lead an interagency working group to evaluate biosecurity and preparedness.

The office would include an “industry liaison” at the beginning of response to a health threat to coordinate private sector involvement in any response efforts.

The provision that would create the new office was part of a larger pandemic preparedness package assembled by Senate health committee leaders Patty Murray (D-Wash.) and Richard Burr (R-N.C.). Lawmakers are aiming to pass the broader government funding package by Friday to avert a shutdown.

“We routinely underinvest in, and underappreciate, these key dimensions of preparedness. Having a pandemic response office, with a director appointed by White House, is an important development,” Morrison said.





Source link

Previous Post

Olorofim Under Review for Invasive Fungal Infections

Next Post

Medical Bulletin 23/December/2022

Next Post

Medical Bulletin 23/December/2022

Recommended

Open access to research can close gaps for people with disabilities

September 6, 2022

Health Bulletin 18/January/2023

January 18, 2023

Don't miss it

Pharmaceutical

Strange bedfellows lobby for Medicare obesity-drug coverage

January 26, 2023
Medicines & Healthy Lifestyle

FDA Panel Votes on Rezafungin for Treatment of Candidemia, Invasive Candidiasis

January 26, 2023
Medicines & Healthy Lifestyle

This Cancer Drug Can Increase Longevity, Study Finds

January 26, 2023
News

Something in Breast Milk Helps Protect Babies Against Allergies

January 26, 2023
Pharmaceutical

Merck ends late-stage trial for Keytruda in prostate cancer

January 25, 2023
Medicines & Healthy Lifestyle

Are Seed Oils Behind the Majority of Diseases This Century?

January 25, 2023

© 2022 Medical News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us

Newsletter Sign Up

No Result
View All Result
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us

© 2022 Medical News Hubb All rights reserved.